SHAW CHRISTINE (VP, Assay Development) reported 1 transaction at GENMARK DIAGNOSTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/6/2021ACC: 0001487371-21-000142
Officer· VP, Assay Development
Since Aug 2020
-1.73K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
1.73K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.73K
Price / share
—
Trade value
—
% of position
1.7%
4/1/2021
102.20K→100.47K
Total
Net shares
−1.73K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2021 | F · Tax Withholding | −1.73K | — | — | 1.7% | 102.20K | 100.47K |
| Total | −1.73K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported